Baebies Inc. announced it raised $37.6 Million in an initial filing from an offering of $50 Million

Company

Location

About

We are guided by the vision that "everyone deserves a healthy start." Our team develops and commercializes products and services that enable early disease detection and comprehensive diagnosis. Baebies' products are powered by digital microfluidics (DMF), an innovative technology to electronically manipulate microliter-sized drops of liquid. We miniaturize conventional diagnostic testing to enable faster results using smaller sample sizes. Our testing platforms provide the answers you need while decreasing potential harm experienced from frequent invasive testing on the most vulnerable patients. Over 12 million tests delivered, and counting. Every test is a chance to save a life.